OssDsign AB Logo

OssDsign AB

Developer of orthobiologics for bone regeneration in spinal fusion surgery.

OSSD | ST

Overview

Corporate Details

ISIN(s):
SE0012570448
LEI:
5493005SNS5NAYE2WL53
Country:
Sweden
Address:
Ulls väg 29C, 756 51 Uppsala

Description

OssDsign is a developer and global provider of next-generation orthobiologics products based on advanced material science. The company develops and markets products that support the body's own healing capabilities, with a primary focus on bone regeneration for spinal fusion surgery. Its flagship product, OssDsign Catalyst®, is a nanosynthetic bone graft putty engineered to engage dual bone formation pathways, promoting rapid and reliable bone formation. OssDsign Catalyst® is the first synthetic bone graft to receive clearance for on-label interbody use based on bone graft data alone, allowing it to be used in any interbody cage cleared for use with synthetic bone grafts. This unique regulatory status, combined with its handling characteristics, differentiates the product in the orthobiologics market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OssDsign AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OssDsign AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OssDsign AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cuorips Inc. Logo
Develops iPS cell-derived therapies and provides cell processing contract services.
Japan
4894
Cuprina Holdings (Cayman) LTD Logo
Biomedical firm developing wound care biotherapy and cosmeceutical products.
United States of America
CUPR
Curanex Pharmaceuticals Inc Logo
Develops botanical drugs for inflammatory diseases like ulcerative colitis.
United States of America
CURX
Curasight A/S Logo
A clinical-stage biotech developing a theranostic platform for cancer diagnosis and treatment.
Denmark
CURAS
Curevac Logo
A biopharmaceutical company developing therapies based on messenger RNA (mRNA) technology.
Germany
CVAC
CureVac N.V. Logo
A biopharmaceutical company developing mRNA-based medicines for a range of diseases.
United States of America
CVAC
CURIS INC Logo
Biotechnology company developing and commercializing therapeutics for cancer treatment.
United States of America
CRIS
Curocell Inc. Logo
A clinical-stage biotech developing CAR-T therapies for blood cancers.
South Korea
372320
CYBIN INC. Logo
A late-stage neuropsychiatry company developing psychedelic-based therapeutics.
United States of America
CYBN
Cyclerion Therapeutics, Inc. Logo
Develops personalized biofeedback therapies for treatment-resistant depression.
United States of America
CYCN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.